These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2575662)

  • 1. Oklahoma blood center to study human retroviruses in donors.
    J Okla State Med Assoc; 1989 Nov; 82(11):580. PubMed ID: 2575662
    [No Abstract]   [Full Text] [Related]  

  • 2. [Residual risk of retrovirus transmission by transfusions].
    Soriano V; Heredia A
    Rev Clin Esp; 1995 Jun; 195(6):418-24. PubMed ID: 7644794
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevalence of HBV, HCV, HIV-1, 2 and HTLV-I/II infections among blood donors in a teaching hospital in the Central region of Saudi Arabia.
    El-Hazmi MM
    Saudi Med J; 2004 Jan; 25(1):26-33. PubMed ID: 14758374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survey of the seroprovalence of HTLV I/II in hemodialysis patients and blood donors in Urmia.
    Khameneh ZR; Baradaran M; Sepehrvand N
    Saudi J Kidney Dis Transpl; 2008 Sep; 19(5):838-41. PubMed ID: 18711311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Infection with T-lymphotropic virus in Dutch blood donors, 1993-1996].
    Zaaijer HL; Lelie PN; van der Poel CL
    Ned Tijdschr Geneeskd; 1997 Aug; 141(32):1571-2. PubMed ID: 9543753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for HTLV-III antibodies: the relation between prevalence and positive predictive value and its social consequences.
    JAMA; 1985 Jun; 253(23):3395-8. PubMed ID: 2987557
    [No Abstract]   [Full Text] [Related]  

  • 7. [The risk of retrovirus transmission by blood transfusions].
    Soriano V; Tor J; Ribera A
    An Med Interna; 1989 Dec; 6(12):611-3. PubMed ID: 2562367
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevalence of human T-lymphotropic virus type I and type II antibody among blood donors in Eastern Saudi Arabia.
    Ul-Hassan Z; Al-Bahrani AT; Panhotra BR
    Saudi Med J; 2004 Oct; 25(10):1419-22. PubMed ID: 15494814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HTLV in the Americas.
    Proietti FA; Carneiro-Proietti AB
    Rev Panam Salud Publica; 2006 Jan; 19(1):7-8. PubMed ID: 16536933
    [No Abstract]   [Full Text] [Related]  

  • 10. Seroprevalence of HTLV-I/II in blood donors in Monterrey, Mexico.
    Trejo-Avila LM; Fuentes-Pensamiento R; Scorro Flores-Castañeda M; Diaz-Mendoza ML; Zapata-Benavides P; Tamez-Guerra RS
    Arch Med Res; 1996; 27(1):97-9. PubMed ID: 8867376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retroviruses: new viral infections in man.
    Salahuddin SZ; Markham PD
    Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S107-19. PubMed ID: 2899867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Determination of anti-HTLV-I/II antibodies: Experience in 28,897 blood donations in Buenos Aires].
    Blejer JL; Saguier MC; Salamone HJ; Carreras LA
    Sangre (Barc); 1995 Dec; 40(6):447-51. PubMed ID: 8850226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquired immunodeficiency syndrome: review of epidemiology.
    Cameron HD
    J Okla State Med Assoc; 1986 Jan; 79(1):11-6. PubMed ID: 3007708
    [No Abstract]   [Full Text] [Related]  

  • 14. Blood donor testing for HIV-I/II and HTLV-I/II.
    Ness PM; Nass CC
    Arch Pathol Lab Med; 1994 Apr; 118(4):337-41. PubMed ID: 7909428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of human T-cell leukemia virus types I and II in Switzerland.
    Böni J; Bisset LR; Burckhardt JJ; Joller-Jemelka HI; Bürgisser P; Perrin L; Gorgievski M; Erb P; Fierz W; Piffaretti JC; Schüpbach J;
    J Med Virol; 2004 Feb; 72(2):328-37. PubMed ID: 14695678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevalence of human T-lymphotropic virus, Type 1 and 2 in blood donors and patients with sexually transmissible diseases in Surinam].
    Alberga H; Goubau P; Desmyter J; Carton H
    Ned Tijdschr Geneeskd; 1996 Aug; 140(33):1689-92. PubMed ID: 8830293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Seroepidemiologic data on viral infections (HTLV-I and LAV/HTLV-III) in the Caribbean region and intertropical Africa].
    de Thé G; Gessain A
    Ann Pathol; 1986; 6(4-5):261-4. PubMed ID: 2880599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is seroprevalence of HTLV-I/II among blood donors in India relevant?
    Kumar H; Gupta PK
    Indian J Pathol Microbiol; 2006 Oct; 49(4):532-4. PubMed ID: 17183844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is seroprevalence of HTLV-I/II among blood donors in Lebanon relevant?
    Tamim H; Musharrafieh U; Ramia S; Almawi WY; Al-Jisr T; Ayoub T; Nabulsi-Majzoub M; Kazma H; Baz EK
    Am J Infect Control; 2004 Jun; 32(4):220-3. PubMed ID: 15175617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Absence of HTLV-I/II virus circulation in blood donors from the provinces of Santa Fe and Santiago del Estero].
    Gastaldello R; Fazzola P; Caeiro L; Maturano E; Perez De Rosas A; Fernandez I; Racca R; Rodriguez MB; Molina M; Alonso S; Gallego S
    Rev Argent Microbiol; 2002; 34(2):107-9. PubMed ID: 12180256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.